DIABINESE Drug Patent Profile
✉ Email this page to a colleague
When do Diabinese patents expire, and what generic alternatives are available?
Diabinese is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in DIABINESE is chlorpropamide. There are eleven drug master file entries for this compound. Additional details are available on the chlorpropamide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DIABINESE?
- What are the global sales for DIABINESE?
- What is Average Wholesale Price for DIABINESE?
Summary for DIABINESE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 112 |
| Clinical Trials: | 1 |
| Patent Applications: | 3,555 |
| DailyMed Link: | DIABINESE at DailyMed |
Recent Clinical Trials for DIABINESE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Novartis | Phase 2 |
US Patents and Regulatory Information for DIABINESE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | DIABINESE | chlorpropamide | TABLET;ORAL | 011641-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pfizer | DIABINESE | chlorpropamide | TABLET;ORAL | 011641-006 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
